The impact of a Telehealth-based Behavioral Lifestyle Program on hypertension control in African American participants: results from the HEALS Med-Tech randomized controlled trial-Reference-Cited by-同舟云学术

The impact of a Telehealth-based Behavioral Lifestyle Program on hypertension control in African American participants: results from the HEALS Med-Tech randomized controlled trial

Published:2024-02-09 Issue:1 Volume:20 Page:309-312
ISSN:1734-1922
Container-title:Archives of Medical Science
language:
Short-container-title:Arch Med Sci

Author:

Dodani Sunita Dodani¹,Clarke Amanda²,El Moudden Ismail²,Gunawardena Tharidu²,Bedi Navdhit³

Affiliation:

1. Center 4 Health Research, University of Illinois, College of Medicine, Illinois, United States

2. Healthcare Analytics and Delivery Science Institute (HADSI), Eastern Virginia Medical School, Virginia, United States

3. Department of Biological Sciences, Clemson University, South Carolina, United States

Abstract

IntroductionThe HEALS Med-Tech program offers a unique blend of lifestyle changes and technology to improve hypertension (HTN) management in African Americans (AAs), a group disproportionately affected by cardiovascular disease (CVD).MethodsA randomized controlled trial compared HEALS Med-Tech against usual care for uncontrolled hypertension in AAs, focusing on diet, medication adherence, and telehealth.ResultsIn a study of 61 participants, HEALS Med-Tech significantly reduced systolic blood pressure by 12.95 mm Hg (p = 0.008) and 9.19 mm Hg (p = 0.013) at 3 and 12 months, respectively, demonstrating improved hypertension control.ConclusionsHEALS Med-Tech demonstrates potential in HTN management for AAs, advocating for culturally tailored, tech-integrated healthcare expansion.

Publisher

Termedia Sp. z.o.o.

Link

https://www.archivesofmedicalscience.com/pdf-177686-104917

Reference17 articles.

1. Mensah GA, Wei GS, Sorlie PD, et al. Decline in cardiovascular mortality. Circ Res 2017; 120: 366-80.

2. Wu S, Chen D, Zeng X, et al. Arterial stiffness is associated with target organ damage in subjects with pre-hypertension. Arch Med Sci 2018; 14: 1374-80.

3. Chobanian AV. The hypertension paradox – more uncontrolled disease despite improved therapy. N Engl J Med 2009; 361: 878-87.

4. Yusuf S, Joseph P, Rangarajan S, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet 2020; 395: 795-808.

5. Fryar C, Ostchega Y, Hales C, Zhang G, Kruszon-Moran D. Hypertension prevalence and control among adults: United States, 2015–2016. NCHS data brief, no 289. Hyattsville, MD: National Center for Health Statistics. 2017.